Compound Diisopropylamine Dichloroacetate Injection – (Shibeixin) – 20?mg Low price comparison

DescriptionCompound Diisopropylamine Dichloroacetate (commonly known as DADA injection, brand Shibeixin) combines diisopropylamine dichloroacetate with sodium gluconate. DADA, a derivative of pangamic acid (“Vitamin B15”), is a hepatoprotective agent that enhances metabolic enzyme activity, supports liver detoxification, and improves bile flow. The injectable form is suitable for experimental and pharmacological studies on liver disorders, such as fatty liver, hepatic impairment, and early-stage cirrhosis.Shibeixin is produced by Hunan Wuzhoutong Pharmaceutical Co., Ltd., following NMPA approval H20067194. Packaged as sterile liquid, 1?ml (20?mg) per vial × 10 vials. Contents hide 1 Product Specifications 2 Mechanism of Action 3 Research Applications 4 Safety & Handling 5 Core Keywords 6 Research Use Disclaimer Product SpecificationsParameterDetailsProduct NameCompound Diisopropylamine Dichloroacetate Injection (Shibeixin)Active IngredientDiisopropylamine Dichloroacetate (DADA) Sodium GluconateCAS Number (DADA)660?27?5Molecular Formula (DADA)C?H??Cl?NO?Molecular Weight (DADA)230.13?g/molAppearanceClear, colorless sterile injection solutionStrength20?mg per 1?ml vialPack Size10 vials per boxDosage FormInjectable solutionApproval NumberH20067194 (NMPA, China)ManufacturerHunan Wuzhoutong Pharmaceutical Co., Ltd.BarcodeNot yet assigned—ask for packaging dataStorage ConditionsStore ??25?°C, avoid lightIntended UseLab research—liver protection, metabolism, bile secretion studiesMechanism of ActionDADA enhances liver metabolism by stimulating hepatic phospholipid methylation, increasing membrane fluidity, and activating Na?/K??ATPase. It supports mitochondrial respiration and promotes bile secretion, aiding in reducing fatty accumulation in hepatocytes.Research ApplicationsFatty liver disease modelsHepatic bile secretion and cholestasis studiesLiver function recovery assaysHepatitis and early fibrosis/pre-cirrhosis experimentsNADH/NAD metabolism and mitochondrial respiration researchSafety & HandlingUse appropriate lab PPE (gloves, gown, eye protection)Intended for lab/experimental use only—no clinical administrationReported mild adverse effects in clinical contexts: dizziness, nausea, hypotensionStore sealed, away from moisture and lightCore KeywordsDADA injection, compound diisopropylamine dichloroacetate, pangamic acid injection, Shibeixin injection, fatty liver research, liver metabolism injection, bile secretion enhancer, hepatoprotective injectionResearch Use DisclaimerThis product is strictly for laboratory/research use. It is not approved for clinical, diagnostic, therapeutic, or veterinary applications. Misuse may pose legal or health risks—follow institutional protocols.